Press Release Aebi Schmidt Group declares quarterly dividend of $0.025 per share and will announce second quarter 2026 earnings on August 13, 2026 Aebi Schmidt Group / Aebi Schmidt Holding AG · Jul 21
Press Release R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis R1 Therapeutics · Jul 21
Press Release Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T Tempest Therapeutics · Jul 21
Press Release Payroll Influences Announces Launch of 2026 Payroll Profession Confidence Index Survey Payroll Influences · Jul 21
Press Release Denodo Honors Outstanding Customer Implementations Across 10 Key Industry Verticals Denodo Technologies Inc. (“Denodo”) · Jul 21
Press Release Omai Gold to Present at the Precious Metals & Critical Minerals Virtual Investor Conference on July 23rd Virtual Investor Conferences · Jul 21
Press Release Q2 Metals Reports Final Winter Assays with Intercept of 137.6 Metres Grading 1.47% Li₂O, Including 40.6 Metres at 3.25% Li₂O at the Cisco Lithium Project in Quebec, Canada Q2 Metals Corp · Jul 21
Press Release Bitdeer Announces June 2026 Production and Operations Update Bitdeer Technologies Group · Jul 21
Press Release New York Times Bestselling Author, Psychiatrist to Hunter Biden, and Executive Coach Keith Ablow Explores Radical Reinvention in New Novel Pain2Power Coaching · Jul 21
Press Release Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis Nektar Therapeutics · Jul 21